Skip to main content

Published locations for FDA restricts obeticholic acid (Ocaliva) over serious liver injury risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA restricts obeticholic acid (Ocaliva) over serious liver injury risk

User login

  • Reset your password
  • /content/fda-restricts-obeticholic-acid-ocaliva-over-serious-liver-injury-risk
  • /clinicianreviews/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over-serious
  • /familypracticenews/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over
  • /gihepnews/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over-serious-liver
  • /internalmedicinenews/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over
  • /jcomjournal/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over-serious
  • /internalmedicine/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over-serious
  • /familymedicine/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over-serious
  • /emergencymedicine/article/240676/gastroenterology/fda-restricts-obeticholic-acid-ocaliva-over